Bionano Genomics, Inc. (BNGO) Capital expenditures 2017–2025
Bionano Genomics, Inc. (BNGO) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2017: $1.0M → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $103,000 | -93.9% |
| FY2023 | $1.7M | -29.8% |
| FY2022 | $2.4M | — |
| FY2020 | $0 | -100.0% |
| FY2019 | $61,056 | -81.6% |
| FY2018 | $331,716 | -67.4% |
| FY2017 | $1.0M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice